The North American journal GEN reports on research performed by Natàlia Carulla, with the Peptides and Proteins Group at IRB, on beta-amyloid aggregates and their relation with Alzheimer’s disease. The study concludes that the most harmful aggregates for neurons are intermediate accumulations of beta-amyloid, these ranging from between 20 and 100 units.
IProteos, a spin-off from IRB Barcelona labs and co-funded by the researchers Teresa Tarragó and Ernest Giralt, has received the prize Expoquimia R+D+I for a new drug under development for the treatment of schizophrenia.
The scientific reporter Pere Estupinyà talks to representatives from business, research, political and educational circles to find out whether Catalonia is prepared for a production model based on the generation of knowledge. Estupinyà also visits labs at IRB Barcelona, at the Barcelona Science Park, where he speaks to Joan J Guinovart, director of the centre. Guinovart explains that research centres funded by the Catalan Government have three critical characteristics that make them competitive, namely "administrative flexibility, recruitment flexibility, and responsibility for the results achieved." The director of IRB Barcelona also...
To mark World Alzheimer's Day on 21 September, the newspaper ARA publishes an article about research trends into Alzheimer's disease. The article includes mention of the project led by Patrick Aloy on AD and funded by an ERC Consolidator Grant.
Joan J. Guinovart publishes an article in El País about the contributions of Emilio Botín, president of Bank of Santader who recently died at the age of 79, to the advancement of the science in Spain.
Feature article published in the Spanish science news website Excelenciencia about the IRB Barcelona initiatives to bring closer the science to the society. The aim behind the new approaches included in the article are to inform and attracting new donations.
Atraer donaciones con un clic (in Spanish)
In an article published in La Vanguardia on sleep disorders, Salvador Aznar-Benitah explains the existence of a cellular biological clock and the consequences of its alteration. According to Aznar-Benitah this cellular clock "makes all the cells in our body to know exactly what time is it."
Lluís Ribas is consulted in an article published in Materia about the discovery of a new antibiotic produced by a harmless bacterium present in the human body. This antibiotic acts as a natural defense against other bacteria and opens the door to finding new antibiotics through the analysis of small molecules with bacterial origin in the human body. According to Ribas, an expert on the development of new antibiotics and founder of Omnia Molecular, the potential of this discovery as a way to generate new antibiotics is "incredible."
Marco Milán (Development and Growth Control Lab) interviewed in Catalunya Ràdio about the uses of Drosophila melanogaster for biomedical reseacher. IRB Barcelona is a pioneer in the use of flies to study human conditions like cancer and genetic diseases.
Several media echo on the research lead by Ernest Giralt focused on the use of wasp venom as a strategy to kill cancer cells selectively.